Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Seminars in Arthritis and Rheumatism|March 23, 2017
Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? A systematic reviewClaudia Mendoza-Pinto, Carmelo Pirone, Daniëlle A van der Windt, et al.
Oxford Medical Case Reports|June 1, 2023
A successful antenatal outcome in a patient with refractory Takayasu's arteritis treated with tocilizumab throughout pregnancy-a case reportBehram Khan, Trixy David, Jon Sussman, et al.
The Journal of Rheumatology|February 12, 2009
Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosusMandana Nikpour, Dafna D Gladman, Dominique Ibañez, et al.
Arthritis and Rheumatism|April 3, 2008
The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritisSophia M Naz, Tracey M Farragher, Diane K Bunn, et al.
Scientific Reports|March 2, 2016
Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosusJohn A Reynolds, Sahena Haque, Kate Williamson, et al.
Lupus Science & Medicine|July 27, 2024
Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD)Jessica Ellis, Neil McHugh, John D Pauling, et al.
Autoimmunity Reviews|May 25, 2025
Dual B-cell targeting in systemic lupus erythematosus: The role of combined and sequential therapy with rituximab and belimumabBeatriz Frade-Sosa, Juan C Sarmiento-Monroy, Ian N Bruce, et al.
Pharmacoeconomics|January 31, 2012
Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisalHuiqin Yang, Dawn Craig, David Epstein, et al.
Annals of the Rheumatic Diseases|January 16, 2007
HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritisPauline Y P C Ho, Anne Barton, Jane Worthington, et al.
Lupus Science & Medicine|May 31, 2022
Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trialStephen McDonald, Sean Yiu, Li Su, et al.
Pageof 22